IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results – BioSpace

IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results – BioSpace
IRLAB to Advance Clinical Development of IRL790 in LIDs Based on In-depth Analysis of Positive Phase IIa Results  BioSpacePublished: Aug 28, 2019. STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- IRLAB (Nasdaq First North Premier: IRLAB A) today announced that the in-depth ... read more
Source: Google NewsPublished on 2019-08-28